KR940011003A - Angiogenesis Inhibitor Composition Containing Ursolic Acid - Google Patents

Angiogenesis Inhibitor Composition Containing Ursolic Acid Download PDF

Info

Publication number
KR940011003A
KR940011003A KR1019920021116A KR920021116A KR940011003A KR 940011003 A KR940011003 A KR 940011003A KR 1019920021116 A KR1019920021116 A KR 1019920021116A KR 920021116 A KR920021116 A KR 920021116A KR 940011003 A KR940011003 A KR 940011003A
Authority
KR
South Korea
Prior art keywords
ursolic acid
composition containing
angiogenesis inhibitor
inhibitor composition
containing ursolic
Prior art date
Application number
KR1019920021116A
Other languages
Korean (ko)
Other versions
KR960004026B1 (en
Inventor
김규원
정해영
손경희
Original Assignee
김규원
정해영
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김규원, 정해영 filed Critical 김규원
Priority to KR1019920021116A priority Critical patent/KR960004026B1/en
Publication of KR940011003A publication Critical patent/KR940011003A/en
Application granted granted Critical
Publication of KR960004026B1 publication Critical patent/KR960004026B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn

Abstract

본 발명은, 우르솔린산을 함유하는 혈관 형성 억제제 조성물에 관한 것으로, 비파엽으로부터 추출한 우르솔린산을 수정란에서 배의 형성시 호흡에 관여하는 융모요막에 처리하였을 때 혈관의 생성을 억제하는 작용을 나타내는 것을 확인하였으며, 이것은 암을 비롯한 과다한 혈관 형성과 관련된 질병의 치료에 적용할 수 있다.The present invention relates to an angiogenesis inhibitor composition containing ursolic acid, wherein the ursolic acid extracted from the non-leaflets has an effect of inhibiting the formation of blood vessels when treated with chorionic ureteres involved in respiration during embryonic formation in fertilized eggs. It is applicable to the treatment of diseases related to excessive blood vessel formation including cancer.

Description

우르솔린산을 함유하는 혈관형성 억제제 조성물Angiogenesis Inhibitor Composition Containing Ursolic Acid

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

제1도는 우르솔린산과 레티노산으로 처리하였을 때 CAM에서의 혈관 형성이 억제됨을 보여주는 사진이다.FIG. 1 is a photograph showing that blood vessel formation in CAM is inhibited when treated with ursolic acid and retinoic acid.

Claims (2)

유효성분인 우르솔린산을 1∼10㎍의 양으로 함유함을 특징으로 하는 혈관형성억제제 조성물.An angiogenesis inhibitor composition comprising ursolic acid as an active ingredient in an amount of 1 to 10 µg. 제1항에 있어서, 우르솔린산은 비파엽(Eriobotrta japonisa L)로부터 얻은 것임을 특징으로 하는 조성물.The composition of claim 1, wherein the ursolic acid is obtained from Eriobotrta japonisa L. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019920021116A 1992-11-11 1992-11-11 Angiogenesis inhibitor composition comprising ursolic acid KR960004026B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019920021116A KR960004026B1 (en) 1992-11-11 1992-11-11 Angiogenesis inhibitor composition comprising ursolic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019920021116A KR960004026B1 (en) 1992-11-11 1992-11-11 Angiogenesis inhibitor composition comprising ursolic acid

Publications (2)

Publication Number Publication Date
KR940011003A true KR940011003A (en) 1994-06-20
KR960004026B1 KR960004026B1 (en) 1996-03-25

Family

ID=19342885

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920021116A KR960004026B1 (en) 1992-11-11 1992-11-11 Angiogenesis inhibitor composition comprising ursolic acid

Country Status (1)

Country Link
KR (1) KR960004026B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1320356C (en) * 2004-12-09 2007-06-06 上海雷允上药业有限公司 Method for detecting Kidney tonifying mind easing extractive quality standard
KR20120109783A (en) * 2011-03-28 2012-10-09 주식회사한국전통의학연구소 Composition for treatment of lung cancer and functional food comprising extract of eriobotriae folium

Also Published As

Publication number Publication date
KR960004026B1 (en) 1996-03-25

Similar Documents

Publication Publication Date Title
RU93048466A (en) APPLICATION OF BENZOTHIOPHENES FOR PREVENTION AND TREATMENT OF OSTEOPOROSIS AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
ATE188609T1 (en) COMPOSITION CONTAINING FERTILIZED SHELL EGGS
NL7904144A (en) FATTY ACID PREPARATIONS FOR THE TREATMENT AND PREVENTION OF THROMBO EMBOLY.
ATE73334T1 (en) ANTIOESTROGENIC DRUG FOR PERCUTANEOUS ADMINISTRATION.
KR970706002A (en) Use of Aromatase Inhibitors in the Preparation of a Drug for Relative Androgen Deficiency in Men in the Preparation of a Medicament for the Treatment of Relative Androgen Deficiency in Male
DE69431601D1 (en) NEW USE OF DEXMEDETOMIDIN
ATE152628T1 (en) USE OF PARATHORMONES, ITS BIOLOGICALLY ACTIVE FRAGMENTS OR RELATED PEPTIDES FOR THE TREATMENT OF PREGNANCY
DE69314234D1 (en) Preserved polysiloxane emulsion for the treatment of tissues
ATE211908T1 (en) INTRAVENOUS SOLUTION THAT REDUCES PROTEIN AND WATER LOSS IN THE BODY
KR890004693A (en) How to treat male baldness and unwanted hair growth
KR910007509A (en) Injection composition for lipophilic pharmaceutical
KR940011003A (en) Angiogenesis Inhibitor Composition Containing Ursolic Acid
ATE3416T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES AND MEDICATIONS CONTAINING THEM.
DE69522702D1 (en) A STABLE AQUEOUS INFUSION SOLUTION CONTAINING A THROMBIN INHIBITOR
KR940011004A (en) Angiogenesis inhibitor composition containing oleanolic acid
DE69230790D1 (en) Medicines used to treat protozoal infections caused by Babesia
KR880009656A (en) Treatment or prophylaxis of local periodontal disease
DE69424679D1 (en) COMPOSITION FOR TREATING OR PREVENTING HERPES
ATE212853T1 (en) SYNERGISTIC ORAL COMPOSITIONS CONTAINING A COMBINATION OF SALMON DNA WITH HYDROXYPROLINE
TW328049B (en) Penciclover/propylene glycol composition
ATE42201T1 (en) USE OF PHYTOSTEROL GLYCOSIDES IN THE MANUFACTURE OF PHARMACEUTICALS FOR THE TREATMENT OF INCREASED 5(6)ALPHA-EPOXYCHOLESTEROL LEVELS.
DE69626276D1 (en) TETRONIC ACID DERIVATIVES FOR TREATING HIV AND OTHER RETROVIRUS DISEASES
KR910007540A (en) Prevention and treatment of blood cell reduction disorder
RU96107872A (en) TALITA FACE SKIN CREAM
KR960033467A (en) Mucin secretion inhibitors

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20120305

Year of fee payment: 17

EXPY Expiration of term